✦ LIBER ✦

The Efficacy of Adult Christian Support Groups in Coping with the Death of a Significant Loved One

✍ Scribed by Herbert Goodman; Mark H. Stone

Book ID: 106426245
Publisher: Springer
Year: 2008
Tongue: English
Weight: 182 KB
Volume: 48
Category: Article
ISSN: 0022-4197
DOI: 10.1007/s10943-008-9201-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Role of Attachment in Predicting Spi

The Role of Attachment in Predicting Spiritual Coping with a Loved One in Surgery

✍ Timothy G. Belavich; Kenneth I. Pargament 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 112 KB

The safety and efficacy of a powered too

The safety and efficacy of a powered toothbrush on soft tissues in patients with implant-supported fixed prostheses

✍ B. Vandekerckhove; M. Quirynen; P. R. Warren; J. Strate; D. van Steenberghe 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 202 KB

Effect of Aging on the Amide Group of Bo

Effect of Aging on the Amide Group of Bone Matrix, Measured by FTIR Spectrophotometry, in Adult Subjects Deceased as a Result of Violent Death

✍ J.-M. Very; R. Gibert; B. Guilhot; M. Debout; C. Alexandre 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 403 KB

Consolidation with alemtuzumab in patien

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)

✍ Wendtner, C-M; Ritgen, M; Schweighofer, C D; Fingerle-Rowson, G; Campe, H; Jäger 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Efficacy and toxicity of 2 schedules of

Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma : A randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA)

✍ Vincent Ribrag; Christian Gisselbrecht; Corinne Haioun; Gilles Salles; Jean-Bapt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Efficacy and safety of the PPARγ partial

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

✍ Kim Henriksen; Inger Byrjalsen; Per Qvist; Henning Beck-Nielsen; Gitte Hansen; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

## Abstract ## Background Treatment of patients with perioxisome proliferator‐activated receptor‐γ full agonists are associated with weight gain, heart failure, peripheral oedema, and bone loss. However, the safety of partial perioxisome proliferator‐activated receptor‐γ agonists has not been esta